OK so Pfizer will pay USD $11.6 billion for an approved treatment for migraine headaches eh? They think that they can acquire RAP for 1/165th of that sum? It works out around USD $1.1 billion for RAP at Taurean7's fair value figure. Line up the potential of RAP in the short/medium term against the merits of a migraine headache treatment...
I just had a thought...why not get the mainstream media who announced the $100 million bid for RAP by Pfizer to print the story about the massive swing to a RAP Shareholder No Vote. Will make a great story with everyone contributing as a group to the letter and incl. Taurean7's value assessment too...That will signal to the financial world and investing public what the real situation really is! The Shareholders of ResApp Health gather together to prevent Pfizer takeover from succeeding! (Headline) The media will love it and create momentum and hype...interviews with shareholders etc...lets keep the snowball rolling. My goodness I haven't ever seen anything as cool as that assessment from Taurean7...I suspect maybe a barrister...just my hunch!
- Forums
- ASX - By Stock
- RAP
- Valuing ResApp Health
Valuing ResApp Health, page-37
-
- There are more pages in this discussion • 430 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online